Literature DB >> 18753201

Double-stranded RNA adenosine deaminases enhance expression of human immunodeficiency virus type 1 proteins.

Angsana Phuphuakrat1, Romchat Kraiwong, Chompunuch Boonarkart, Darat Lauhakirti, Tun-Hou Lee, Prasert Auewarakul.   

Abstract

ADARs (adenosine deaminases that act on double-stranded RNA) are RNA editing enzymes that catalyze a change from adenosine to inosine, which is then recognized as guanosine by translational machinery. We demonstrate here that overexpression of ADARs but not of an ADAR mutant lacking editing activity could upregulate human immunodeficiency virus type 1 (HIV-1) structural protein expression and viral production. Knockdown of ADAR1 by RNA silencing inhibited HIV-1 production. Viral RNA harvested from transfected ADAR1-knocked-down cells showed a decrease in the level of unspliced RNA transcripts. Overexpression of ADAR1 induced editing at a specific site in the env gene, and a mutant with the edited sequence was expressed more efficiently than the wild-type viral genome. These data suggested the role of ADAR in modulation of HIV-1 replication. Our data demonstrate a novel mechanism in which HIV-1 employs host RNA modification machinery for posttranscriptional regulation of viral protein expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18753201      PMCID: PMC2573204          DOI: 10.1128/JVI.00238-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Identification and validation of endogenous reference genes for expression profiling of T helper cell differentiation by quantitative real-time RT-PCR.

Authors:  H K Hamalainen; J C Tubman; S Vikman; T Kyrölä; E Ylikoski; J A Warrington; R Lahesmaa
Journal:  Anal Biochem       Date:  2001-12-01       Impact factor: 3.365

2.  DNA deamination mediates innate immunity to retroviral infection.

Authors:  Reuben S Harris; Kate N Bishop; Ann M Sheehy; Heather M Craig; Svend K Petersen-Mahrt; Ian N Watt; Michael S Neuberger; Michael H Malim
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

3.  Inhibition of hepatitis delta virus RNA editing by short inhibitory RNA-mediated knockdown of ADAR1 but not ADAR2 expression.

Authors:  Geetha C Jayan; John L Casey
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  The role of binding domains for dsRNA and Z-DNA in the in vivo editing of minimal substrates by ADAR1.

Authors:  A Herbert; A Rich
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-09       Impact factor: 11.205

5.  Widespread inosine-containing mRNA in lymphocytes regulated by ADAR1 in response to inflammation.

Authors:  Jing-Hua Yang; Xiaoxing Luo; Yongzhan Nie; Yingjun Su; Qingchuan Zhao; Koroush Kabir; Dexin Zhang; Reuven Rabinovici
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

6.  Hepatitis delta virus minimal substrates competent for editing by ADAR1 and ADAR2.

Authors:  S Sato; S K Wong; D W Lazinski
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

7.  Construction and analysis of an infectious human Immunodeficiency virus type 1 subtype C molecular clone.

Authors:  T Ndung'u; B Renjifo; M Essex
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

8.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.

Authors:  Ann M Sheehy; Nathan C Gaddis; Jonathan D Choi; Michael H Malim
Journal:  Nature       Date:  2002-07-14       Impact factor: 49.962

9.  CRM1 mediates the export of ADAR1 through a nuclear export signal within the Z-DNA binding domain.

Authors:  H Poulsen; J Nilsson; C K Damgaard; J Egebjerg; J Kjems
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

10.  Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling.

Authors:  Dirk Holzinger; Carl Jorns; Silke Stertz; Stéphanie Boisson-Dupuis; Robert Thimme; Manfred Weidmann; Jean-Laurent Casanova; Otto Haller; Georg Kochs
Journal:  J Virol       Date:  2007-05-09       Impact factor: 5.103

View more
  45 in total

Review 1.  Substitutional A-to-I RNA editing.

Authors:  Bjorn-Erik Wulff; Kazuko Nishikura
Journal:  Wiley Interdiscip Rev RNA       Date:  2010 Jul-Aug       Impact factor: 9.957

2.  Adenosine deaminase acting on RNA 1 (ADAR1) suppresses the induction of interferon by measles virus.

Authors:  Zhiqun Li; Kristina M Okonski; Charles E Samuel
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

Review 3.  Adenosine deaminases acting on RNA, RNA editing, and interferon action.

Authors:  Cyril X George; Zhenji Gan; Yong Liu; Charles E Samuel
Journal:  J Interferon Cytokine Res       Date:  2010-12-23       Impact factor: 2.607

Review 4.  Enhancement of replication of RNA viruses by ADAR1 via RNA editing and inhibition of RNA-activated protein kinase.

Authors:  Jean-François Gélinas; Guerline Clerzius; Eileen Shaw; Anne Gatignol
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

Review 5.  Tipping the balance: antagonism of PKR kinase and ADAR1 deaminase functions by virus gene products.

Authors:  Cyril X George; Zhiqun Li; Kristina M Okonski; Ann M Toth; Ying Wang; Charles E Samuel
Journal:  J Interferon Cytokine Res       Date:  2009-09       Impact factor: 2.607

Review 6.  ADARs: viruses and innate immunity.

Authors:  Charles E Samuel
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

7.  Diverse selective regimes shape genetic diversity at ADAR genes and at their coding targets.

Authors:  Diego Forni; Alessandra Mozzi; Chiara Pontremoli; Jacopo Vertemara; Uberto Pozzoli; Mara Biasin; Nereo Bresolin; Mario Clerici; Rachele Cagliani; Manuela Sironi
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

8.  ADAR1 interacts with PKR during human immunodeficiency virus infection of lymphocytes and contributes to viral replication.

Authors:  Guerline Clerzius; Jean-François Gélinas; Aïcha Daher; Marion Bonnet; Eliane F Meurs; Anne Gatignol
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

Review 9.  Mouse models for Aicardi-Goutières syndrome provide clues to the molecular pathogenesis of systemic autoimmunity.

Authors:  R Behrendt; A Roers
Journal:  Clin Exp Immunol       Date:  2014-01       Impact factor: 4.330

10.  Editing of HIV-1 RNA by the double-stranded RNA deaminase ADAR1 stimulates viral infection.

Authors:  Margherita Doria; Francesca Neri; Angela Gallo; Maria Giulia Farace; Alessandro Michienzi
Journal:  Nucleic Acids Res       Date:  2009-08-03       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.